Open Access

Novel insights regarding the sigmoidal pattern of resistance to neomycin conferred by the aphII gene, in Streptomyces lividans

AMB Express20133:13

DOI: 10.1186/2191-0855-3-13

Received: 30 January 2013

Accepted: 4 February 2013

Published: 8 February 2013

Abstract

A library of synthetic promoters of various strengths, specifically constructed for Streptomyces species, was cloned in the promoter-probe plasmid pIJ487, upstream of the promoter-less aphII gene that confers resistance to neomycin. The survival rates conferred by promoters were assessed in the presence of 100 μg.ml−1 neomycin. The correlation between the transcriptional activity of the aphII gene (estimated by RT-PCR) and the resistance to neomycin (expressed as survival rate) indicated a sigmoid rather than a linear correlation. In this issue, we propose a tentative explanation for this sigmoidal pattern of resistance in relation with the level of aph II gene expression. Beyond this specific example, our model might constitute a sound explanation for the generally observed but never explained sigmoidal shape of classical inhibition curves obtained in the presence of linearly increasing antibiotic concentrations.

Keywords

Bacteria Gene expression/regulation Growth and survival Modelling

Introduction

Antibiotics have been the most useful therapeutic agents of the twentieth century (Levy 2002). However, more and more bacteria have developed resistance to all existing antibiotics and antimicrobial resistance was recently recognized as one of the greatest threats to human health (Gyssens 2011). Indeed an increasing number of patients suffer from serious life-threatening antimicrobial-resistant infections against which only very few, if any, effective antibiotics are available (Levy 1998). Alarmingly, as the number of patients dying from antibiotic-resistant infections rises, the number of new antibiotics in development is plummeting (Butler and Cooper 2012; Mahajan and Balachandran 2012). The antibiotic resistance genes acquired by human pathogens are thought to originate from micro-organisms of the environment including Streptomyces (Forsberg et al. 2012). These bacteria are antibiotic producers and thus contain the corresponding antibiotic resistance genes for self protection (Allen et al. 2010; Davies and Davies 2010; Nikaido 2009). The genes conferring resistance to antibiotics are spreading by horizontal transfer in the microbial population and the release of antimicrobials in the environment likely selects micro-organisms carrying these genes (Alonso et al. 2001; Martinez 2008). The mechanisms conferring antibiotic resistance in micro-organisms include enzymatic inactivation or modification of the antibiotic, modification of host targets to prevent antibiotic binding, efflux pumps. A major challenge to counteract the development of resistance to antibiotic treatment is to get a better understanding of how bacteria react to antibiotics.

The efficiency of many antibiotics is known to be impaired by the existence of resistance mechanisms. In this study, an antibiotic resistance gene, aph II, was used to assess the impact of the level of expression of this gene on survival to an antibiotic selective pressure. aph II encodes a phosphotransferase, phosphorylating the aminoglycoside antibiotic, neomycin, impairing its ability to interact with the ribosome and thus preventing inhibition of mRMA translation by neomycin (Beck et al. 1982; Hermann 2007). The expression of this gene present on the multicopy plasmid pIJ487 (Ward et al. 1986) was put under the control of 18 promoters of varying strengths originating from a previous study (Seghezzi et al. 2011). These different constructs were introduced into Streptomyces lividans and survival of these different clones, exposed to a constant and rather high concentration of neomycin (100 μg/ml), was assessed.

Our results revealed that the relation between promoter strength (as determined by RT-PCR) and survival rate was not linear but indicated a sigmoidal correlation. A model, consistent with this behaviour, based on the well-known mechanism by which aminoglycoside antibiotics are lethal to bacteria, and how AphII counteracts this poisoning activity, was designed and discussed. This model might have a more general scope to rationalize the currently observed but never explained sigmoidal shape of classical inhibition curve obtained with linearly increasing antibiotic concentrations (Baudoux et al. 2007).

Materials and methods

Bacterial strains, plasmid and media

Streptomyces lividans TK24 strains transformed with 38 pIJ487-derived plasmids, each carrying a 300 bp DNA fragment with promoter activity of various strength were used in this study (Ward et al. 1986). The strength of these promoters was previously roughly estimated, using the replica-plating technique as described in ( Lederberg and Lederberg 1952). These promoters were classified as weak, medium or strong based on their ability to allow growth of the different transformants in the presence of up to 20, 50 or 100 μg.ml−1 of neomycin in HT medium (Seghezzi et al. 2011). Media as well as Streptomyces manipulations were carried out according to Practical Streptomyces Genetics manual (Kieser et al. 2000). SFM was used to grow up transformants to prepare spores suspensions for quantitative estimation of survival rates.

Estimation of survival rates

Glycerol stocks of spores of the different transformants made on SFM medium were precisely titrated by plating different spore dilutions on HT agar containing 50 μg.ml−1 thiostrepton. Subsequently, 102 and 103 spores of each transformant were spread out on HT agar plates containing 50 μg.ml−1 thiostrepton only or 50 μg.ml−1 thiostrepton and 100 μg.ml−1 neomycin. Neomycin resistant colonies were counted after incubation for 72 hours at 30°C and viability rates were calculated relative to the number of colonies on neomycin free plates. These platings, done in duplicate, gave very similar viability counts and the means are shown in Figure 1.
Figure 1

Survival rates conferred by promoters of different strength on HT medium containing 100 μg.ml -1 neomycin. Promoters strength was initially roughly assessed by patch replica plating on HT medium containing different concentrations of neomycin. Transcriptional activity conferred by the promoters indicated in bold as well as that originating from control plasmids (promoter-less pIJ487 and pIJ487ermE*) were determined by RT-PCR.

Estimation of aphII transcriptional activity using RT-PCR

RNA was extracted, using RNeasy Mini Kit from Qiagen, from selected transformants representative of each strength class and grown for 48h on the surface of cellophane disks laid on solid HT medium containing only 50 μg.ml−1 thiostrepton.

RT PCR was performed using the OneStep RT-PCR Kit from Qiagen and the following conditions: initial denaturation at 97°C, 5 min followed by 25 cycles of denaturation (97°C, 30 s), annealing (50°C, 30 s) and extension (72°C, 30 s). The absence of DNA in RNA samples was systematically checked by running a control PCR reaction made in absence of reverse transcription. Quantification of the RT-PCR signals was made using ImageQuant pixel counts in non-saturated conditions. Values were normalised on pIJ487 signals. The normalisation was done with the negative control that is the plasmid pIJ487 with no promoter cloned upstream of aph II. Some weak transcription of aph II was detected in this context.

Results

Assessment of promoter strength using viability assays and RT-PCR

An accurate quantification of promoter strength, expressed as survival rate, was carried out in the presence of 100 μg.ml-1 neomycin, for 38 selected clones belonging to a previously constructed bank of synthetic promoter designed for Streptomyces species and fused to the reporter gene aphII conferring resistance to neomycin. These promoters were previously roughly classified as weak, medium and strong by replicate plating (Seghezzi et al. 2011). A transformant containing pIJ487ermE* carrying the strong ermE* promoter was used as a positive control (Bibb et al. 1985). It should be stressed that in a genetically homogenous bacterial population, all the bacteria are not in the same physiological state and the expression of aphII (as that of any other genes) varies stochastically around a mean value (Elowitz et al. 2002; Losick and Desplan 2008). This variability explains why, even when a weak promoter is driving aphII expression, a small fraction of the bacterial population is able to resist to a high level of neomycin.

Eighteen of these transformants, representative of each class of promoter strength (weak, medium and strong) were precisely ranked according to the survival rate they conferred in the presence of 100 μg.ml-1 neomycin. All colonies had approximately the same size. Each promoter was plotted against the log of the survival rate it conferred in the presence of 100 μg.ml-1 neomycin. Interestingly, the resulting curve appears to be sigmoidal (Figure 1). The first and third parts represent the low and high survival rates and the central part of the curve shows an abrupt transition between these two states. We thus wondered whether the transcriptional activity of these promoters followed a similar sigmoidal pattern. To answer this question, we assessed the transcriptional activity of promoters corresponding to the three parts of the curve, using RT-PCR.

Results shown in the Figure 2AB indicated that the transcriptional activity between the weakest and the strongest promoter was approximately 12 fold whereas the corresponding overall increase in the survival rate was in the 106 fold range. Similarly, the two fold increase in the level of expression between the D1-7 and A1-14 promoters led to a 200 fold increase in the survival rate. The level of gene expression was thus plotted versus the survival rates and this plotting (Figure 2C) indicated a non-linear, roughly sigmoidal, correlation between the level of gene expression and the survival rate. We thus proposed an explanatory model that rationalises the sigmoidal pattern of resistance to neomycin observed in relation with the level of aph II gene expression and with the concentration of neomycin used.
Figure 2

Correlation between the level of transcription of the aphII gene and the survival rates of different transformants in the presence of 100 μg.ml -1 neomycin. (A) Assessment of the transcriptional activity of aphII in S. Lividans driven by the promoters highlighted in bold in Figure 1 and the control plasmids, pIJ487 and pIJ487ermE* , using RT-PCR. Clones were ordered from the left to the right according to increasing promoter strength. (B) Quantification of the RT-PCR signals was made using ImageQuant pixel counts in non-saturated conditions. Values were normalized on pIJ487 signals. Survival rates corresponding to each clone are indicated above each histogram. (C) Plotting of the quantification of the RT-PCR products of the different clones versus their corresponding survival rates in presence of 100 μg.ml-1 neomycin.

The model

Our study revealed a sigmoidal correlation between the level of aph II gene expression and the survival rates, in the presence of neomycin 100 μg.ml-1 (Figure 2C). This behaviour is reminiscent of a system containing a positive feedback loop leading to two different states, the transition between the two states being very abrupt (Kaufman et al. 2007; Mehra et al. 2008; Mitrophanov and Groisman 2008). In our case, the positive feedback loop would be constituted by one positive and two negative interactions (Figure 3). Positive interaction (PI): the ribosomes are involved in protein synthesis. Negative interaction (NI1): neomycin poisons the ribosomes leading to an inhibition of protein synthesis, including that of AphII. Negative interaction (NI2): AphII inactivates neomycin. These two negative interactions and the positive one generate a positive circuit. When the expression of aphII is low, AphII is not very abundant so most of neomycin is active and a lot of ribosomes are poisoned. This poisoning leads to a further reduction of AphII and thus to low survival rates (State 1). Conversely, when the expression of aphII is high, AphII is abundant, most neomycin is inactivated so more ribosomes are functional leading to a further enhancement of aph II mRNA translation leading to high survival rates (State 2). A small variation of gene expression around a specific threshold leads to an abrupt switch from one state to the other. Experimentally, the level of expression of the D1-7 promoter was shown to be close to this threshold.
Figure 3

Schematic representation of the two states of the system. State 1: Low survival rates: If the expression of aphII is low, AphII is not abundant and most ribosomes are poisoned. This poisoning leads to a further reduction of AphII abundance and thus to low survival rates. State 2: High survival rates: If the expression of aphII is high, AphII is abundant, more neomycin is inactivated so less ribosomes are poisoned and high survival rates are observed. A small variation of aphII expression around a specific threshold leads to an abrupt switch from one state to the other.

Discussion

The aphII gene is the most extensively used reporter system in Streptomyces, however, this useful system was sometimes blamed for some non-understood paradoxical behaviour. The dynamics of the system, as revealed by our study, can explain these paradoxes. Consequently, the aphII gene should thus be used with caution to accurately assess promoter strength, since a small variation of gene expression around a specific threshold might lead to a huge change in the pattern of resistance to neomycin.

Furthermore, our study suggests that it might be sufficient to reduce (and not totally preclude) the expression of a resistance gene just under a certain threshold to greatly enhance the killing efficiency of the corresponding antibiotic. That is why nowadays even imperfect inhibitors of transcription and/or translation are sometimes associated in prescription to overcome some reluctant antibiotic resistant strains.

At last, it is noteworthy that the sigmoidal shape of our curve is reminiscent of that of classical inhibition curve obtained with linearly increasing concentration of antibiotics (Baudoux et al. 2007; Mattie 2000). This similarity suggests that related processes might take place in a natural strain. Any natural strain, in which no exogenous antibiotic resistance gene was introduced, does possess more or less efficient active antibiotic resistance processes. These processes might include efflux of the antibiotic via multidrug efflux pumps ( Nikaido 2009), built-in target (Criswell et al. 2006; Long et al. 2009) or antibiotic modifications or proteic systems that might counteract the detrimental consequences induced by the antibiotic such as the generation of oxidative stress etc. ( Hassett and Imlay 2007; Kohanski et al. 2007; Shin et al., 2011). Since all these resistance processes involve genes that should be transcribed and mRNA that should be translated, it is not unreasonable to think that any antibiotic targeting the transcriptional or translational apparatus would give rise to a positive circuit resulting in a sigmoidal response (Figure 4). Our model thus might provide a sound explanation for the sigmoidal shape of the inhibition curves that has been repeatedly observed but was never explained.
Figure 4

Model of natural mechanisms of resistance against antibiotics targeting the transcriptional and/or the translational apparatus. The transcriptional and the translational apparatus are involved in protein synthesis (positive interactions PIa, PIb). The lethal effect of an antibiotic relies on its ability to inhibit transcription or translation (first negative interaction, NI1) including that of a gene encoding a protein neutralizing somehow the poisoning effect of the antibiotic (second negative interaction, NI2). The positive and the two negative interactions generate a positive circuit that leads to the establishment of a sigmoidal pattern of resistance to the antibiotic according to the level of expression of the gene responsible for the natural resistance mechanism.

Declarations

Acknowledgements

This work was supported by the European program ACTINOGEN (http://www.swan.ac.uk/ils/Research/BioMed/ActinoGen/), the Centre National de la Recherche Scientifique (http://www.cnrs.fr/), the University Paris Sud (http://www.u-psud.fr) and the Pôle de Recherche et d’Enseignement supérieur UniverSud Paris (http://www.universud-paris.fr).

Authors’ Affiliations

(1)
Institut de Génétique et Microbiologie, UMR8621 CNRS Université Paris-Sud
(2)
Laboratoire de Recherche en Informatique, Université Paris-Sud, UMR8623 CNRS, and INRIA Saclay

References

  1. Allen HK, Donato J, Wang HH, Cloud-Hansen KA, Davies J, Handelsman J: Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol 2010, 8: 251–259. 10.1038/nrmicro2312PubMedView ArticleGoogle Scholar
  2. Alonso A, Sanchez P, Martinez JL: Environmental selection of antibiotic resistance genes. Environ Microbiol 2001, 3: 1–9. 10.1046/j.1462-2920.2001.00161.xPubMedView ArticleGoogle Scholar
  3. Baudoux P, Bles N, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F: Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections. J Antimicrob Chemother 2007, 59: 246–253.PubMedView ArticleGoogle Scholar
  4. Beck E, Ludwig G, Auerswald EA, Reiss B, Schaller H: Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene 1982, 19: 327–336. 10.1016/0378-1119(82)90023-3PubMedView ArticleGoogle Scholar
  5. Bibb MJ, Janssen GR, Ward JM: Cloning and analysis of the promoter region of the erythromycin resistance gene (ermE) of Streptomyces erythraeus. Gene 1985, 38: 215–226. 10.1016/0378-1119(85)90220-3PubMedView ArticleGoogle Scholar
  6. Butler MS, Cooper MA: Screening strategies to identify new antibiotics. Curr Drug Targets 2012, 13: 373–387. 10.2174/138945012799424624PubMedView ArticleGoogle Scholar
  7. Criswell D, Tobiason VL, Lodmell JS, Samuels DS: Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother 2006, 50: 445–452. 10.1128/AAC.50.2.445-452.2006PubMed CentralPubMedView ArticleGoogle Scholar
  8. Davies J, Davies D: Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010, 74: 417–433. 10.1128/MMBR.00016-10PubMed CentralPubMedView ArticleGoogle Scholar
  9. Elowitz MB, Levine AJ, Siggia ED, Swain PS: Stochastic gene expression in a single cell. Science 2002, 297: 1183–1186. 10.1126/science.1070919PubMedView ArticleGoogle Scholar
  10. Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MO, Dantas G: The shared antibiotic resistome of soil bacteria and human pathogens. Science 2012, 337: 1107–1111. 10.1126/science.1220761PubMed CentralPubMedView ArticleGoogle Scholar
  11. Gyssens IC: Antibiotic policy. Int J Antimicrob Agents 2011,38(Suppl):11–20.PubMedView ArticleGoogle Scholar
  12. Hassett DJ, Imlay JA: Bactericidal antibiotics and oxidative stress: a radical proposal. ACS Chem Biol 2007, 2: 708–710. 10.1021/cb700232kPubMedView ArticleGoogle Scholar
  13. Hermann T: Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cell Mol Life Sci 2007, 64: 1841–1852. 10.1007/s00018-007-7034-xPubMedView ArticleGoogle Scholar
  14. Kaufman M, Soule C, Thomas R: A new necessary condition on interaction graphs for multistationarity. J Theor Biol 2007, 248: 675–685. 10.1016/j.jtbi.2007.06.016PubMedView ArticleGoogle Scholar
  15. Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA: Practical Streptomyces Genetics. John Innes centre, Norwich Research Park, Norwich; 2000.Google Scholar
  16. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ: A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130: 797–810. 10.1016/j.cell.2007.06.049PubMedView ArticleGoogle Scholar
  17. Lederberg J, Lederberg EM: Replica plating and indirect selection of bacterial mutants. J Bacteriol 1952, 63: 399–406.PubMed CentralPubMedGoogle Scholar
  18. Levy SB: The challenge of antibiotic resistance. Sci Am 1998, 278: 46–53.PubMedView ArticleGoogle Scholar
  19. Levy SB: The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Power. Da Capo Press, Perseus Publishing, Cambridge, MA, USA; 2002.Google Scholar
  20. Long KS, Poehlsgaard J, Hansen LH, Hobbie SN, Bottger EC, Vester B: Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics in Mycobacterium smegmatis by perturbation of the drug binding pocket. Mol Microbiol 2009, 71: 1218–1227. 10.1111/j.1365-2958.2009.06596.xPubMedView ArticleGoogle Scholar
  21. Losick R, Desplan C: Stochasticity and cell fate. Science 2008, 320: 65–68. 10.1126/science.1147888PubMed CentralPubMedView ArticleGoogle Scholar
  22. Mahajan GB, Balachandran L: Antibacterial agents from actinomycetes - a review. Front Biosci (Elite Ed) 2012, 4: 240–253.View ArticleGoogle Scholar
  23. Martinez JL: Antibiotics and antibiotic resistance genes in natural environments. Science 2008, 321: 365–367. 10.1126/science.1159483PubMedView ArticleGoogle Scholar
  24. Mattie H: Antibiotic efficacy in vivo predicted by in vitro activity. Int J Antimicrob Agents 2000, 14: 91–98. 10.1016/S0924-8579(99)00145-4PubMedView ArticleGoogle Scholar
  25. Mehra S, Charaniya S, Takano E, Hu WS: A bistable gene switch for antibiotic biosynthesis: the butyrolactone regulon in Streptomyces coelicolor. PLoS One 2008, 3: e2724. 10.1371/journal.pone.0002724PubMed CentralPubMedView ArticleGoogle Scholar
  26. Mitrophanov AY, Groisman EA: Positive feedback in cellular control systems. Bioessays 2008, 30: 542–555. 10.1002/bies.20769PubMed CentralPubMedView ArticleGoogle Scholar
  27. Nikaido H: Multidrug resistance in bacteria. Annu Rev Biochem 2009, 78: 119–146. 10.1146/annurev.biochem.78.082907.145923PubMed CentralPubMedView ArticleGoogle Scholar
  28. Seghezzi N, Amar P, Koebmann B, Jensen PR, Virolle MJ: The construction of a library of synthetic promoters revealed some specific features of strong Streptomyces promoters. Appl Microbiol Biotechnol 2011, 90: 615–623. 10.1007/s00253-010-3018-0PubMedView ArticleGoogle Scholar
  29. Shin JH, Singh AK, Cheon DJ, Roe JH: Activation of the SoxR regulon in Streptomyces coelicolor by the extracellular form of the pigmented antibiotic actinorhodin. J Bacteriol 2011, 193: 75–81. 10.1128/JB.00965-10PubMed CentralPubMedView ArticleGoogle Scholar
  30. Ward JM, Janssen GR, Kieser T, Bibb MJ, Buttner MJ: Construction and characterisation of a series of multi-copy promoter-probe plasmid vectors for Streptomyces using the aminoglycoside phosphotransferase gene from Tn5 as indicator. Mol Gen Genet 1986, 203: 468–478. 10.1007/BF00422072PubMedView ArticleGoogle Scholar

Copyright

© Seghezzi et al.; licensee Springer. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.